Sarepta Therapeutics note 1.500% 11/1 shares owned by Morgan Stanley
Quarter-by-quarter ownership of Sarepta Therapeutics note 1.500% 11/1 shares owned by Morgan Stanley
from 13F filings
Historical chart of Morgan Stanley investment in Sarepta Therapeutics note 1.500% 11/1
Tip: Access up to 7 years of quarterly data
All positions including Sarepta Therapeutics note 1.500% 11/1 held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Sarepta Therapeutics note 1.500% 11/1 by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $93k | 52k | 1.79 |
| 2023-09-30 | $3.5k | 2.0k | 1.76 |
| 2023-06-30 | $257k | 152k | 1.69 |
| 2022-12-31 | $3.7k | 2.0k | 1.87 |
| 2022-06-30 | $1.6M | 1.3M | 1.25 |
| 2022-03-31 | $1.8M | 1.4M | 1.31 |
| 2021-06-30 | $8.0M | 6.1M | 1.31 |
| 2020-12-31 | $7.3M | 3.0M | 2.43 |
| 2020-09-30 | $6.1M | 2.9M | 2.06 |
| 2020-06-30 | $5.3M | 2.3M | 2.29 |
| 2020-03-31 | $9.7M | 6.4M | 1.52 |
| 2019-12-31 | $4.2M | 2.2M | 1.94 |
| 2019-09-30 | $4.1M | 3.1M | 1.34 |
| 2019-03-31 | $3.1M | 1.7M | 1.80 |
Top funds holding Sarepta Therapeutics note 1.500% 11/1
View all funds holding Sarepta Therapeutics note 1.500% 11/1